Log in to save to my catalogue

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal...

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_42b3b0c2cdb74855a9ee7e49bcdf3ba0

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

About this item

Full title

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2024-01, Vol.16 (1), p.1-11, Article 1

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Apolipoprotein-E (APOE) genetic testing for Alzheimer's disease is becoming more important as clinical trials are increasingly targeting individuals carrying APOE-ε4 alleles. Little is known about the interest in finding out one's genetic risk for Alzheimer's disease in the general population. Our objective was to examine this in a sample of cognit...

Alternative Titles

Full title

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_42b3b0c2cdb74855a9ee7e49bcdf3ba0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_42b3b0c2cdb74855a9ee7e49bcdf3ba0

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-023-01364-w

How to access this item